<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0009830'>Peripheral neuropathy</z:hpo> (PN) has long been recognized in <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>), but its natural history is an unsettled issue </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, we prospectively assessed 40 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> for 13 months with nerve conduction (NC) studies and the revised total <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> score (TNSr) to study the progression of PN </plain></SENT>
<SENT sid="2" pm="."><plain>There was no significant change in the TNSr score over the follow-up period </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, the average sural sensory nerve action potential (SNAP) amplitude decreased significantly over the same interval from a mean of 13.2 muV to 9.8 muV (P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>There was an inverse correlation between the change in the sural SNAP amplitude and the length of the CAG triplet repeat expansion (r = 0.574, P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>The reduction in the mean sural SNAP amplitude also correlated with progression of <z:hpo ids='HP_0001251'>ataxia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>This indicates that PN progresses faster in individuals with larger (CAG)(n) expansions, and nerve conduction studies may be useful to study disease progression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> </plain></SENT>
</text></document>